Epigenomics
IPOBerlin, Germany · $22.5M raised
- Headquarters
- Berlin
- Business Model
- B2B
- Website
- epigenomics.com
- Total Funding
- $22.5M
- Last Round
- $22.5M Series CApr 2008
- Rounds
- 1
About
Epigenomics AG is a molecular diagnostics company developing blood-based DNA methylation tests for early cancer detection.
Summary
Epigenomics is a Biotech company based in Berlin, Germany. It has raised $22.5M in total across 1 round, most recently a $22.5M Series C round in Apr 2008. Investors include Omega Funds.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2017
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.